Celltrion, Inc. today announced that six abstracts will be presented at the 2025 Digestive Disease Week® (DDW) Annual Meeting, taking place May 3-6 in San Diego, California. The oral and poster ...

Sanofi will halt the development of its oral tumour necrosis factor (TNF) inhibitor balinatunfib as a monotherapy after it ...

With the introduction of a subcutaneous formulation, ENTYVIO has expanded patient convenience and global accessibility. Continued growth is supported by rising IBD prevalence and ongoing geographic ...

The specific mechanisms by which the drugs exert their therapeutic effects differ, however. Humira targets TNF-alpha, while Stelara acts on IL-12 and IL-23. All three molecules are crucial parts of ...

I immediately Google TNF-alpha and find that, worryingly, this cytokine is implicated in acute and chronic inflammatory conditions including, sepsis, rheumatoid arthritis and dementia.

Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parco Area delle Scienze 17/a, 43124 Parma, Italy ...

Infliximab works by blocking a molecule called tumor necrosis factor (TNF), which is a major part of the body’s immune response and is involved in inflammation. By reducing TNF, the drug helps ...

Data suggest that patients with IBD treated with antitumour necrosis factor (TNF ... particularly the initiation of corticosteroid treatment, escalation to infliximab and timely surgical intervention, ...